Screening for Ocular Surface Instability Before Contact-Lens Complications

Abstract

Ocular surface instability is a significant precursor to contact-lens-related complications, including discomfort, infection, and reduced visual performance. Early identification of instability through systematic screening can prevent the onset of adverse outcomes and support optimal contact lens wear. This review synthesizes the latest evidence on screening strategies, risk factors, mechanisms, and clinical management, offering practical guidance for clinicians to identify and mitigate ocular surface instability before complications arise.

Introduction

The increasing prevalence of contact lens usage globally has amplified the clinical importance of preventing complications associated with lens wear. Ocular surface instability, often manifesting as dry eye or tear film dysfunction, is a pivotal factor predisposing patients to contact-lens-related adverse events. Despite advances in lens technology, complications remain a challenge, underscoring the need for robust screening protocols. This article reviews current scientific understanding and clinical approaches to screening ocular surface instability before the onset of contact-lens complications.

Epidemiology / Disease Burden

Contact lens use is widespread, with an estimated 140 million users globally. Epidemiological studies indicate that up to 50% of contact lens wearers experience ocular discomfort, with dry eye symptoms reported in 30%-50% of users. Complications such as contact lens-induced dry eye (CLIDE), giant papillary conjunctivitis, and microbial keratitis can significantly impact quality of life and visual function. The burden is particularly high among younger adults and those using lenses for extended wear, highlighting the need for preventive strategies targeting ocular surface health.

Pathophysiology

Ocular surface instability involves multifactorial mechanisms, including tear film dysfunction, epithelial barrier disruption, and inflammatory cascades. Contact lenses may exacerbate tear film evaporation, disrupt the lipid layer, and promote mechanical microtrauma. These changes can compromise the mucin layer and epithelial integrity, potentiating inflammatory mediator release and destabilizing the ocular surface microenvironment. Persistent instability sets the stage for secondary complications such as infection and allergic reactions, reinforcing the importance of early recognition and intervention.

Risk Factors

Several risk factors contribute to ocular surface instability in contact lens wearers. These include pre-existing dry eye disease, meibomian gland dysfunction, environmental factors (e.g., low humidity, high screen time), systemic medications (antihistamines, antidepressants), poor lens hygiene, and use of certain lens materials. Demographic factors such as age, female sex, and underlying systemic disease (e.g., autoimmune disorders) further elevate risk. Identification of these factors during pre-fitting assessments can inform personalized risk mitigation strategies.

Clinical Features

Early clinical features of ocular surface instability are often nonspecific, including ocular dryness, burning, foreign body sensation, intermittent blurred vision, and lens intolerance. On examination, clinicians may observe conjunctival hyperemia, reduced tear meniscus height, punctate epithelial erosions, and decreased tear break-up time (TBUT). Subtle signs such as lid margin telangiectasia or meibomian gland dropout may indicate underlying evaporative dysfunction. These findings warrant further evaluation before proceeding with contact lens fitting.

Diagnosis

Diagnosis of ocular surface instability requires a combination of patient-reported symptom assessment and objective clinical tests. Standardized questionnaires, such as the Ocular Surface Disease Index (OSDI), help quantify symptom burden. Objective measures include TBUT, Schirmer\'s test, tear osmolarity, and ocular surface staining with fluorescein or lissamine green. Advanced diagnostics may include meibography for gland assessment and interferometry for lipid layer analysis. A comprehensive diagnostic approach enables the identification of subclinical instability and guides appropriate management.

Treatment & Management

Management of ocular surface instability prior to contact lens wear centers on optimizing tear film health and addressing modifiable risk factors. First-line interventions include artificial tears, lid hygiene, warm compresses, and environmental modifications. For candidates with meibomian gland dysfunction, adjunctive therapies such as omega-3 supplementation or thermal pulsation devices may be indicated. Addressing systemic contributors and reviewing medication profiles are essential. Only after stabilization of the ocular surface should contact lens fitting be attempted, with careful selection of lens material and wearing schedule tailored to individual patient needs.

Recent Advances / Emerging Therapies

Recent advances in ocular surface diagnostics and therapeutics have enhanced the ability to detect and manage instability. Novel point-of-care tests for tear film osmolarity and matrix metalloproteinase-9 (MMP-9) offer rapid, in-office assessment of inflammatory activity. Newer lens materials with enhanced biocompatibility, such as silicone hydrogel lenses with surface coatings, have demonstrated improved comfort in patients with mild instability. Investigational therapies targeting tear film lipid composition and anti-inflammatory pathways hold promise for refractory cases. Digital health tools, including telemedicine-based symptom monitoring, are emerging as adjuncts to routine screening.

Guideline Recommendations

Professional guidelines from organizations such as the Tear Film & Ocular Surface Society (TFOS) and the American Academy of Ophthalmology emphasize the necessity of pre-fitting ocular surface assessment. They recommend a structured screening protocol including symptom surveys, examination of the lid margins, and tear film evaluation. Proactive management of diagnosed instability before lens fitting is advised, with re-assessment prior to initiating contact lens wear. Ongoing surveillance during follow-up visits is critical to detect early signs of recurrence or complication.

Conclusion

Systematic screening for ocular surface instability is a cornerstone of safe and successful contact lens practice. By integrating evidence-based risk assessment, advanced diagnostics, and targeted management, clinicians can reduce the incidence of contact-lens-associated complications and enhance patient satisfaction. Continued research and innovation in screening modalities and therapeutics will further refine preventive strategies, supporting optimal ocular surface health in contact lens users.